CCM
UTHR icon

CTC Capital Management’s United Therapeutics UTHR Stock Holding History

CTC Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,400
Closed -$389K – 133
2022
Q4 		$389K Buy
+1,400
New +$353K 0.45% 53

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CTC Capital Management's UTHR Position: Q1 2023 in Review

CTC Capital Management sold out of United Therapeutics (UTHR) in Q1 2023, closing a stake of 1,400 shares — an estimated $389K sold.

CTC Capital Management first reported a position in UTHR in Q4 2022 and held it in 1 quarter. The position peaked at $389K in Q4 2022. 506 funds tracked by Wall St. Rank hold UTHR as of Q1 2023.

  • CTC Capital Management reported no remaining United Therapeutics position as of Q1 2023 after selling out during the quarter.
  • CTC Capital Management sold 1,400 United Therapeutics shares in Q1 2023, an estimated $389K.
  • CTC Capital Management first reported a position in United Therapeutics in Q4 2022 and held it in 1 quarter.
  • CTC Capital Management's United Therapeutics position peaked at $389K in Q4 2022.
  • 506 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2023.

Based on CTC Capital Management's 13F filing for Q1 2023, filed 5 May 2023.